WHIM Syndrome research hub

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients with WHIM Syndrome with Open-Label Extension

This study looks at a new medicine called Mavorixafor for people with WHIM syndrome. It compares the medicine to a dummy pill to see if it helps improve the body's infection-fighting cells and reduce warts and infections. It also checks how safe the medicine is.